Description
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Purity | ≥95% |
|---|---|
| Formula | C18H25N5O5S |
| Formula Wt. | 423.4 |
| Synonym | MGP-pNa |
| Solubility | Soluble in water. |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification. Postgrad Med. 2014 Mar;126(2):54-64. PMID: 24685968.
Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013 Apr;19(4):217-26. PMID: 23375872.
5-HT1A partial agonist, SERT inhibitor.
Viral M2 proton channel blocker.
Fungistatic
inhibits inflammatory signaling
Jumonji histone demethylase inhibitor.
Ester found in Spiraea, Betula, and Gaultheria;...
HDAC6/10 inhibitor.
Synthetic cyclic dinucleotide agonist of STING....
AurKA/B inhibitor.
Marine toxin; actin polymerization inducer.
Furanolactone found in citrus fruits.
mTOR inhibitor.
ERK1/2 inhibitor.
Decreases expression of MMPs, PGE2, and COX-2, ...
Synthesis impurity
RAF inhibitor.
Found in Capsicum; TRPV agonist.
Macrolide originally produced by Streptomyces; ...
Immunodominant peptide epitope occurring in mul...